News + Filings Transactions Holdings
All 13F 13D/G Other
|
Atlas Venture Fund X, L.P.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/16/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Disc Medicine, Inc.
Txns:
| Sold 75,000 shares
@ $52, valued at
$3.9M
Sold 98,000 shares
@ $53, valued at
$5.2M
Sold 2,000 shares
@ $54.8, valued at
$109.6k
Sold 111,069 shares
@ $52.4, valued at
$5.8M
Sold 72,931 shares
@ $52.4, valued at
$3.8M
|
|
01/13/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns:
| Sold 21,683 shares
@ $29.96, valued at
$649.6k
Sold 6,071 shares
@ $29.96, valued at
$181.9k
Sold 77,128 shares
@ $30.29, valued at
$2.3M
Sold 21,592 shares
@ $30.29, valued at
$654k
|
|
01/03/2023 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Disc Medicine, Inc.
Txns:
| Acquired 1,835,799 shares
@ $0 Acquired 882,224 shares
@ $0 |
|
12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2020 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Generation Bio Co.
Txns:
| Disposed of 1,151,882 shares
@ $0 |
|
09/17/2020 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Disposed of 445,339 shares
@ $0 |
|
08/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/23/2019 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on AVROBIO, Inc.
Txns:
| Bought 810,811 shares
@ $18.5, valued at
$15M
|
|
03/22/2019 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Disposed of 726,500 shares
@ $0 Acquired 14,245 shares
@ $0 Sold 14,245 shares
@ $17.86, valued at
$254.4k
|
|
02/14/2019 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Disposed of 631,073 shares
@ $0 |
|
07/26/2018 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Converted 3,439,839 shares
@ $0 Converted 1,013,547 shares
@ $0 Converted 3,439,839 convertible preferred
@ $0 Converted 1,013,547 convertible preferred
@ $0 |
|
06/27/2018 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns:
| Converted 4,746,876 shares
@ $0 Converted 12,061,496 preferred shares
@ $0 Converted 204,339 preferred shares
@ $0 |
|
06/25/2018 |
4
| Atlas Venture Fund X, L.P. (10% Owner) has filed a Form 4 on AVROBIO, Inc.
Txns:
| Converted 806,711 shares
@ $0 Converted 3,044,579 shares
@ $0 Converted 905,188 shares
@ $0 Converted 3,333,333 options to buy
@ $0 Converted 12,580,199 preferred shares
@ $0 Converted 3,740,239 preferred shares
@ $0 |
|
|
|